Iq Capital Fund Iv C Lp investment portfolio

Baseimmune creates AI‑driven, computationally designed antigen therapeutics using advanced protein‑engineering techniques, delivering next‑generation active immunotherapies for chronic diseases. Its platform is marketed to pharmaceutical and biotech firms developing vaccines and immunotherapy

Imperagen Limited is a biotechnology company developing innovative gene‑therapy treatments for rare genetic disorders and advancing ultra‑fast enzyme engineering for the scale‑up of pharmaceutical biocatalysts, targeting patients with unmet medical needs and the pharma/biotech sector.